We are live on ! Find out more

Mid Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TEM
1
Tempus AI
TEM
$9.93B
$9.93B $55.06 5.78%
PODD icon
2
Insulet
PODD
$9.91B
$9.91B $142.85 1.19%
HSIC icon
3
Henry Schein
HSIC
$9.82B
$9.82B $88.08 0.06%
KRYS icon
4
Krystal Biotech
KRYS
$9.81B
$9.81B $331.59 1.57%
PTGX icon
5
Protagonist Therapeutics
PTGX
$9.71B
$9.71B $150 2.83%
BIO icon
6
Bio-Rad Laboratories Class A
BIO
$9.48B
$9.48B $354.54 0.59%
IONS icon
7
Ionis Pharmaceuticals
IONS
$9.46B
$9.46B $56.94 0.67%
SYRE icon
8
Spyre Therapeutics
SYRE
$9.29B
$9.29B $105.33 0.4%
AVTR icon
9
Avantor
AVTR
$9.29B
$9.29B $13.73 1.03%
RGEN icon
10
Repligen
RGEN
$9.21B
$9.21B $163.17 0.45%
QGEN icon
11
Qiagen
QGEN
$9.05B
$9.05B $43.85 3.66%
KYMR icon
12
Kymera Therapeutics
KYMR
$9.03B
$9.03B $108.58 0.99%
CRNX icon
13
Crinetics Pharmaceuticals
CRNX
$8.93B
$8.93B $84.15 0.08%
HQY icon
14
HealthEquity
HQY
$8.93B
$8.93B $106.79 2.06%
PCVX icon
15
Vaxcyte
PCVX
$8.67B
$8.67B $58.29 0.38%
BRKR icon
16
Bruker
BRKR
$8.58B
$8.58B $56.32 5.45%
OSCR icon
17
Oscar Health
OSCR
$8.54B
$8.54B $27.67 0.82%
ATR icon
18
AptarGroup
ATR
$8.5B
$8.5B $133.68 1.28%
ALKS icon
19
Alkermes
ALKS
$8.29B
$8.29B $49.40 0.47%
IMVT icon
20
Immunovant
IMVT
$8.24B
$8.24B $39.89 0.15%
LQDA icon
21
Liquidia Corp
LQDA
$8.1B
$8.1B $91.03 0.9%
RYTM icon
22
Rhythm Pharmaceuticals
RYTM
$7.95B
$7.95B $115.48 0.13%
IBRX icon
23
ImmunityBio
IBRX
$7.94B
$7.94B $7.49 1.96%
TWST icon
24
Twist Bioscience
TWST
$7.83B
$7.83B $124.88 7.96%
PACS icon
25
PACS Group
PACS
$7.67B
$7.67B $48.45 0.02%
1
2 3 4 5

Mid Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 165 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $750B.

The largest by market cap are Tempus AI (TEM) at $9.93B, Insulet (PODD) at $9.91B and Henry Schein (HSIC) at $9.82B.

Among institutional investors, ImmunityBio (IBRX) drew the most net new fund positions in Q1 2026: 145 funds opened new positions, taking total fund holders up 109 (39%) quarter-over-quarter.

  • Combined market cap: $750B across 165 stocks.
  • Mid Cap: market cap between $2B and $10B.
  • Largest constituent: Tempus AI (TEM), $9.93B market cap.
  • Most net new fund positions in Q1 2026: ImmunityBio (IBRX), +109 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.